Prompte

Prompt Therapeutics is a biotechnology company dedicated to transforming cancer drug development into a high-throughput, systematic process. The company utilizes its proprietary NEST™ platform to generate unbiased maps of cancer cell surface proteins and their isoforms, identifying novel targets that are often overlooked by traditional methods. These targets are then matched with optimal therapeutic formats—such as antibody-drug conjugates (ADCs), T-cell engagers, and CAR-T therapies—using the Armory™ screening platform. By assessing millions of target-format combinations at an unprecedented rate, Prompt Therapeutics aims to rapidly identify and develop the most effective biologic treatments for various cancers.